Compare · ENSG vs MD
ENSG vs MD
Side-by-side comparison of The Ensign Group Inc. (ENSG) and Pediatrix Medical Group Inc. (MD): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ENSG and MD operate in Hospital/Nursing Management (Health Care), so they compete in similar markets.
- ENSG is the larger of the two at $10.43B, about 4.8x MD ($2.19B).
- MD has been more active in the news (13 items in the past 4 weeks vs 4 for ENSG).
- MD has more recent analyst coverage (10 ratings vs 6 for ENSG).
- Company
- The Ensign Group Inc.
- Pediatrix Medical Group Inc.
- Price
- -
- -
- Market cap
- $10.43B
- $2.19B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Hospital/Nursing Management
- Hospital/Nursing Management
- Exchange
- NASDAQ
- NYSE
- IPO
- 2007
- News (4w)
- 4
- 13
- Recent ratings
- 6
- 10
The Ensign Group Inc.
The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. It operates in two segments, Transitional and Skilled Services and Real Estate. The company offers transitional and skilled services, which include short and long-term nursing care services for patients with chronic conditions, prolonged illness, and the elderly; and physical, occupational, and speech therapies and other rehabilitative and healthcare services. It also provides standard services, such as room and board, special nutritional program, social, recreational, entertainment, and other services. In addition, the company offers senior living, as well as mobile diagnostics services; leases real estate properties; and provides other ancillary services consisting of digital x-ray, ultrasound, electrocardiogram, laboratory, sub-acute, and patient transportation services to people in their homes or at long-term care facilities. As of February 2, 2021, it operated 232 healthcare facilities in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington, and Wisconsin. The company was founded in 1999 and is based in San Juan Capistrano, California.
Pediatrix Medical Group Inc.
MEDNAX, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, ultrasonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. As of March 16, 2021, it operated a network of approximately 2,300 physicians. The company was founded in 1979 and is based in Sunrise, Florida.
Latest ENSG
- The Ensign Group Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
- The Ensign Group Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Regulation FD Disclosure, Financial Statements and Exhibits
- The Ensign Group Increases Credit Facility to $800 Million and Extends Maturity
- President and COO Burton Spencer gifted 2,500 shares, decreasing direct ownership by 4% to 65,970 units (SEC Form 4)
- Director Blouin Ann Scott sold $68,829 worth of shares (375 units at $183.54) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 23,677 units (SEC Form 4)
- The Ensign Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- The Ensign Group Reports Second Quarter 2026 Results
- SEC Form 10-Q filed by The Ensign Group Inc.
- Director Agwunobi John O sold $67,056 worth of shares (392 units at $171.06) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 9,503 units (SEC Form 4)
- Director Smith Barry M was granted 600 shares, increasing direct ownership by 3% to 21,952 units (SEC Form 4)
Latest MD
- Pediatrix Medical Group downgraded by Jefferies with a new price target
- Director Young Sylvia Jean returned $492,470 worth of shares to the company (18,500 units at $26.62), decreasing direct ownership by 38% to 29,786 units (SEC Form 4)
- Director Sansone Guy P was granted 472 shares, increasing direct ownership by 0.54% to 87,416 units (SEC Form 4)
- Director Starcher John M. Jr. was granted 472 shares, increasing direct ownership by 0.64% to 73,732 units (SEC Form 4)
- Director Young Sylvia Jean was granted 472 shares, increasing direct ownership by 0.99% to 48,286 units (SEC Form 4)
- Director Rucker Michael A. was granted 472 shares, increasing direct ownership by 0.71% to 66,769 units (SEC Form 4)
- Director Newman Kurt Douglas was granted 472 shares, increasing direct ownership by 3% to 17,405 units (SEC Form 4)
- Director Linynsky Laura A was granted 472 shares, increasing direct ownership by 1% to 39,900 units (SEC Form 4)
- Director Weis Shirley A was granted 472 shares, increasing direct ownership by 3% to 19,095 units (SEC Form 4)
- Director Mceachin Thomas was granted 472 shares, increasing direct ownership by 7% to 7,668 units (SEC Form 4)